Pihla Miettinen

Pihla Miettinen currently serves as the Chief Operating Officer and Laboratory and Research Coordinator at Medicortex Finland Oyj since August 2022. Previously, Pihla worked at the University of Turku, where involvement included an MDP Thesis Project focused on the effects of the NFkB risk allele on astrocytic activation in multiple sclerosis patients from September 2021 to December 2022, and as a Research Assistant studying the effects of PREP inhibition on tau aggregation from May 2021 to July 2021. Pihla holds a Master of Science in Human Neuroscience from the University of Turku (2020-2022) and a Bachelor of Science in Neuroscience with Psychology from the University of Aberdeen (2016-2020), along with an International Baccalaureate diploma (2013-2016).